| Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial | |
| Wei, Lai; Xie, Qing; Hou, Jinlin; Tang, Hong; Ning, Qin; Cheng, Jun; Nan, Yuemin; Zhang, Lunli; Li, Jun; Jiang, Jianning | |
| 刊名 | HEPATOLOGY
 |
| 2017 | |
| 卷号 | 66 |
| ISSN号 | 0270-9139 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3537583 |
| 专题 | 吉林大学白求恩第一医院 |
| 推荐引用方式 GB/T 7714 | Wei, Lai,Xie, Qing,Hou, Jinlin,et al. Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial[J]. HEPATOLOGY,2017,66. |
| APA | Wei, Lai.,Xie, Qing.,Hou, Jinlin.,Tang, Hong.,Ning, Qin.,...&Duan, Zhongping.(2017).Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial.HEPATOLOGY,66. |
| MLA | Wei, Lai,et al."Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial".HEPATOLOGY 66(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论